Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1825-2026

Philips Spectral CT on Rails. Recall

Philips Spectral CT on Rails. Model Number: 728334.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Philips Spectral CT on Rails.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1825-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Mar 7, 2026
FDA report date
Apr 22, 2026
Quantity in commerce
3 systems
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Philips Spectral CT on Rails. Model Number: 728334.

Affected model & UDI checker

Search the exact identifiers published for Z-1825-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
728334.Philips Spectral CT on Rails.Check source notice00884838103627
728334Philips Spectral CT on Rails.Check source noticeNot specified
FDA code information

Model Number: 728334. UDI: (01)00884838103627(21)1005, (01)00884838103627(21)1006, (01)00884838103627(21)1007. Software Version Number: 5.1.X. Serial Numbers: 1005, 1006, 1007.

View the original FDA recall notice

Why was this product recalled?

Philips has identified three software issues: 1. During a continuous CT (CCT) scan, there is the potential that the Gantry could remain at the current scan position after pressing Go. 2. Potential where the message of Previous Surview Exists Select Previous Surview? <Yes> or <No> should display but does not appear. 3. After performing Surview and planning the Brain Helical acquisition by setting Brain Area DoseRight Index to increase the dose, there is the potential that the Define Head Area option in the context menu is grayed out.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did PHILIPS MEDICAL SYSTEMS take?

Philips Medical notified consignees on about 03/07/2026 via letter. Consignees were instructed to identify any affected systems in inventory and specifically for each issue: 1. Issue #1: Ensure to follow the instructions mentioned in the IFU Section 4 Preparing for an Examination and Sub section Gantry Operation. 2. Issue #2: Avoid the Select Previous Surview Unavailable issue, manually remove the patient's middle name while importing the patient detail from HIS/RIS. 3. Issue #3: if Define Head Area option is grayed out with DoseRight Index (DRI) on, review the dose levels displayed on the User Interface, confirm and adjust the dose settings to appropriate levels before executing the scan as instructed in the IFU. Consignees were also instructed to complete and return the response form, to circulate the Urgent Medical Device Correction Letter to all users of the affected device so that they are aware of the issues, and retain the letter with affected system(s) until a solution is installed on each system; ensure the letter is in a place likely to be seen/viewed. Philips will contact each consignee to schedule a time for a Philips Field Service Engineer (FSE) to visit each site and install the solution to resolve the issues (reference FCO72800830).

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology